Neogen CORP Form 4 insider transactions

NEOGEN Director James C. Borel converts 2,025 Restricted Stock Units into common stock.

NEOGEN Director Avi Pelossof reported the acquisition of 19,386 shares of common stock and 49,929 derivative securities, effective October 24, 2025.

NEOGEN Director Catherine E Woteki acquired 19,769 shares of common stock and 50,814 derivative securities (rights to buy) on October 23, 2025.

NEOGEN Director Andrea F Wainer acquired 19,769 shares of common stock and 50,814 derivative securities, signaling increased insider ownership.

NEOGEN Director Rafael A. Rodriguez acquired 19,769 shares of common stock and 50,814 derivative securities at $6.07 per share, increasing his beneficial ownership.

NEOGEN Director Aashima Gupta reported the acquisition of 19,769 shares of common stock and 50,814 derivative securities (rights to buy common stock) at an exercise price of $6.07, effective October 23, 2025.

NEOGEN Corp. Director Ronald D. Green reported the acquisition of 19,769 shares of common stock and 50,814 derivative securities on October 23, 2025.

NEOGEN Director Jeffrey D. Capello acquired additional common stock and derivative securities, increasing his beneficial ownership.

NEOGEN Director Thierry Bernard acquired 19,769 shares of common stock and 50,814 derivative securities, signaling increased insider ownership.

NEOGEN Corp. Director James C. Borel acquired 19,769 shares of common stock and 50,814 derivative securities, signaling confidence.

NEOGEN's Chief Legal Officer, Amy M. Rocklin, reported the vesting and settlement of 294 Restricted Stock Units into common stock, followed by a sale of 115 shares for tax purposes.

Douglas Edward Jones, former COO of NEOGEN CORP, reported the vesting of Restricted Stock Units and subsequent adjustment of his common stock holdings.

NEOGEN's former CEO, John Edward Adent, reported the scheduled vesting and settlement of Restricted Stock Units into common stock, followed by a disposition for tax purposes.

NEOGEN's Chief Legal Officer, Amy M. Rocklin, reported the vesting of 9,036 Restricted Stock Units and a subsequent sale of 3,534 shares for tax purposes on October 7, 2025.

Douglas Edward Jones, former COO of NEOGEN CORP, reported the vesting and settlement of Restricted Stock Units and subsequent disposition of shares for tax purposes.

Former NEOGEN CEO John Edward Adent exercised Restricted Stock Units, acquiring 32,936 shares of common stock and disposing of 9,297 shares for tax purposes.

NEOGEN Director Catherine E. Woteki acquired 2,071 shares of common stock through the vesting and settlement of Restricted Stock Units.

NEOGEN Director James P. Tobin converted 2,071 Restricted Stock Units into common stock on October 7, 2025, increasing his direct beneficial ownership to 39,545 shares.

NEOGEN Director Rafael A. Rodriguez converted 2,071 Restricted Stock Units into common stock on October 7, 2025, increasing his direct beneficial ownership to 17,019 shares.

NEOGEN Director Aashima Gupta acquired 2,071 shares of common stock through the vesting and settlement of Restricted Stock Units.

NEOGEN Director Ronald D. Green converted 2,071 Restricted Stock Units into common stock on October 7, 2025, increasing his direct beneficial ownership to 14,852 shares.

NEOGEN Director Jeffrey D. Capello acquired 2,071 shares of common stock through the vesting and settlement of Restricted Stock Units.

NEOGEN Director James C. Borel converted 2,071 Restricted Stock Units into common stock on October 7, 2025, increasing his direct beneficial ownership to 92,545 shares.

NEOGEN Director William T. Boehm converted 2,071 Restricted Stock Units into common stock on October 7, 2025.

NEOGEN CEO John Edward Adent acquired 35,736 shares of common stock through the conversion of Restricted Stock Units at a price of $5.43 per share.

NEOGEN's Chief Operating Officer, Douglas Edward Jones, acquired 14,294 shares of common stock through the vesting of Restricted Stock Units, while also disposing of 4,160 shares for tax purposes.

NEOGEN's CFO, David H. Naemura, reported the vesting of restricted stock units and subsequent sale of shares for tax purposes.

NEOGEN's Chief Legal Officer, Amy M. Rocklin, reported the vesting of restricted stock units and subsequent stock transactions.

NEOGEN's Chief Accounting Officer, John Patrick Moylan, acquired 1,985 shares of common stock through RSU vesting and disposed of 593 shares for tax purposes.

NEOGEN's CFO, David H. Naemura, acquired 230,203 shares of common stock and 591,690 stock options, effective August 15, 2025, as part of compensation.